l‐Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin
- 6 July 2006
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 574 (2) , 573-581
- https://doi.org/10.1113/jphysiol.2006.108993
Abstract
Full expression of reflex cutaneous vasodilatation is dependent on nitric oxide (NO) and vasodilatation is attenuated in healthy older humans. NO bioavailability in aged skin may be decreased by an age-related upregulation of arginase, which reciprocally regulates the NO-synthase (NOS) substrate L-arginine (L-Arg). We hypothesized that increased arginase activity contributes to attenuated vasodilatation in aged skin by limiting L-Arg for NOS-mediated NO synthesis. Five microdialysis fibres were placed in forearm skin of 10 young (Y, 23 +/- 1 years) and 9 older (O, 68 +/- 1 years) human subjects, serving as control (C, Ringer solution), NOS-inhibited (10.0 mM NG-nitro-L-arginine), arginase-inhibited (5.0 mM (S)-(2-boronoethyl)-L-cysteine + 5.0 mM Nomega-hydroxy-nor-L-arginine), L-arg supplemented (L-Arg; 10.0 mM L-arginine) and combined arginase-inhibited + L-Arg sites. After 20 min thermoneutral baseline, cutaneous vasodilatation was induced by passive whole-body heating to increase oral temperature (Tor) by 1.0 degrees C. Red blood cell flux was measured by laser-Doppler flowmetry over each microdialysis site. Cutaneous vascular conductance was calculated (CVC = flux/mean arterial pressure) and normalized to maximal CVC (CVCmax, 28.0 mM sodium nitroprusside + local heating to 43 degrees C). Cutaneous vasodilatation during heating was attenuated in O (Y, 42 +/- 1, versus O, 30 +/- 1%CVCmax, P < 0.001) at control sites. NOS inhibition decreased vasodilatation in both age groups compared to C (Y, 22 +/- 2; O, 18 +/- 2%CVCmax; P < 0.001). Arginase inhibition, L-Arg supplementation, and arginase inhibition + L-Arg supplementation augmented vasodilatation in O (arginase-inhibited, 46 +/- 4; L-Arg, 44 +/- 4; arginase-inhibited + L-arg, 46 +/- 5%CVCmax; P < 0.001 versus C) but not in Y (arginase-inhibited, 46 +/- 4; L-Arg, 38 +/- 4; arginase-inhibited + L-Arg, 44 +/- 4%CVCmax; P > 0.05 versus C). Increasing L-Arg for NO synthesis by either arginase inhibition or direct L-Arg supplementation restores the age-related deficit in reflex cutaneous vasodilatation.Keywords
This publication has 32 references indexed in Scilit:
- Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old RatsHypertension, 2006
- Asymmetric dimethylarginine (ADMA): the silent transition from an ‘uraemic toxin’ to a global cardiovascular risk moleculeEuropean Journal of Clinical Investigation, 2005
- Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skinJournal of Applied Physiology, 2004
- In vivo and in vitro evidence for ACh-stimulated l-arginine uptakeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Evidence for a Role for Vasoactive Intestinal Peptide in Active Vasodilatation in the Cutaneous Vasculature of HumansThe Journal of Physiology, 2003
- Nitric oxide is not permissive for cutaneous active vasodilatation in humansThe Journal of Physiology, 2003
- Nitric oxide is not permissive for cutaneous active vasodilatation in humansThe Journal of Physiology, 2003
- Aging-Associated Endothelial Dysfunction in Humans Is Reversed by L-ArginineJournal of the American College of Cardiology, 1996
- Nitric Oxide Synthases: Properties and Catalytic MechanismAnnual Review of Physiology, 1995
- Inhibition of arginase by in alveolar macrophages: implications for the utilization of l‐arginine for nitric oxide synthesisFEBS Letters, 1995